




an aseptically obtained culture of f luid or tissue; iii) pain or 
tenderness; iv) localised swelling, redness or heat; and v) a 
superficial incision deliberately opened by a surgeon that is 
culture-positive or not cultured.(1,2) 
Deep sternal wound infection (DSWI) is defined as an infec-
tion that occurs within 30 days after surgery, if there is no 
implant in situ. An implant includes any non-human foreign 
body that is permanently placed in a patient, including screws, 
mesh, and/or wires that are left permanently (e.g. this includes 
prosthetic valves, and bovine valves) or within one year if 
the implant has been left in place. DSWI involves tissues or 
spaces beneath the subcutaneous tissues and meets at least 
one of the following criteria: i) an infective organism isolated 
from culture of the mediastinal tissue or fluid; ii) evidence of 
mediastinitis seen during the operation; iii) chest pain; iv) sternal 
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Sternal wound infection (SWI) is an important complication of 
sternotomy post-cardiac surgery in adults and children and is 
associated with significant mortality and morbidity. It is classi-
fied into superficial and deep sternal wound infections accord-
ing to the US Centers for Disease Control and Prevention 
(CDC).(1,2) Superficial sternal wound infection (SSWI) is defined 
as an infection that occurs within 30 days of surgery and involves 
only the skin or subcutaneous tissue at the incision site.(3) 
Additionally, a superficial infection must meet one of the fol-
lowing criteria: i) purulent drainage; ii) organisms isolated from 
Purpose: Sternal wound infection (SWI) is associated 
with signifi cant morbidity and mortality in post-opera-
tive cardiac patients. We aimed to describe the burden, 
risk factors and outcomes of SWI in post-operative 
paediatric cardiac patients at a tertiary children’s 
hospital. 
Methods: We conducted a retrospective record review 
of cardiac surgeries via median sternotomy over a 
5-year period to identify cases of SWI. 
Results: Between 2011 and 2016, 1 319 patients under-
went median sternotomy. Thirty four (2.6%) patients 
developed SWI; 18 (13%) patients developed deep ster-
nal wound infection (DSWI), and 16 (12%) developed 
superfi cial sternal wound infections (SSWI). Twenty 
two (16%) of SWIs were apparent within a week post-
surgery before discharge, and the remaining were re-
admitted post-discharge. Seven (0.5%) patients died 
from complications. 
Conclusion: Signifi cant morbidity was associated with 
SWI. Furthermore, with a mortality rate of 20% in the 
case of DSWI, we strongly support quality improve-
ment procedures such as the Sternal Wound Preven-
tion Bundle (SWPB) that was introduced in late 2014. 
However, the rate of SWI implies that ongoing moni-
toring and evaluation of the SWPB is necessary and 
more stringent adherence to the protocol may result in 
better outcomes.  SAHeart 2020;17:78-89
Post cardiac surgery sternal wound sepsis 
burden, risk factors and outcomes at 
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instability; or v) fever (>38°C). In addition, it includes any 
purulent discharge from the mediastinum or an organism iso-
lated from blood or drainage culture of the mediastinal area, 
abscess or other evidence of infection involving the deep 
incision found on direct examination, during reoperation or by 
histopathologic or radiologic examination and/or spontaneous 
incisional dehiscence.(1,2)
Paediatric cardiac surgery infections have a reported incidence 
as high as 15% - 30%.(4-7) Studies from Europe and the United 
States reported an incidence of SSWI of 0.5% - 8%, with an 
associated morbidity and mortality rate of 0.5% - 9%.(8-10) 
DSWI has an incidence of 1% - 5%.(11) The overall world-
wide incidence of SWI is reported to be between 0.5% and 
7.5%.(12-16) 
The most common pathogens implicated in sternal wound 
sepsis are Staphylococcus aureus, coagulase-negative Staphy-
lococcus, Pseudomonas aeruginosa, and Salmonella species.(17) 
Different studies have reported various risk factors for the 
development of sternal wound infection post-cardiac surgery. 
These include bypass time of longer than 1 hour, significant 
post-operative bleeding and a low cardiac output state per-
sisting for more than 24 hours post-operatively.(17,18) A post-
operative stay of more than 12 days in a paediatric intensive 
care unit (PICU) increases the risk of SWI signif icantly.(17) 
Pollock, et al.(19) reported an association between SWI occur-
rence and high Paediatric Risk of Mortality (PRIM) score. 
Mehta, et al.(20) showed that younger age, underlying disease 
and higher American Society of Anaesthesiology (ASA) score 
were risk factors for infection, while Allpress, et al.(21) deter-
mined that age less than 1 month and longer surgical time were 
risk factors. Furthermore, a multicentre study described post-
operative inotropic support as an independent risk factor.(22) 
Moreover, Delgado-Corcoran, et al.(23) reported the presence 
of genetic abnormalities, pre-operative hospitalisation, venti-
lator support, extracorporeal membrane oxygenation (ECMO) 
use, and delayed sternal closure (DSC) as risk factors of surgical 
site infections (SSIs) in children. 
Despite these findings that SWI causes significant mortality and 
morbidity in both children and adults post cardiac surgery, 
there are no national guidelines in South Africa to help surgical 
programmes reduce infection rates. Several international pro-
grammes have been described, with reduction of SWIs as a 
primary goal. In response to inconsistent compliance with infec-
tion prevention measures in the US, the Centers for Medicare 
FIGURE 1: Outline to assess eligibility for enrolment.
Others = left posterolateral thoracotomy, right posterolateral thoracotomy, left anterior thoracotomy, right anterior thoracotomy; 




















Surgical management of wounds includes dressing with 
Primapore® dressing and the wound is reviewed on day 2 or 
3 post-surgery. Sternal sutures are subcutaneous and there-
fore are not removed. SSWIs are cleaned or explored and 
vacuum dressings applied in the first instance. DSWIs are 
aggressively debrided in theatre and vaccum dressings are 
applied. Further, a follow up “re-look” in theatre as required 
and vaccum dressing is continued until the wound is ready for 
secondary closure.
An SWPB was introduced at RCWMH in September 2014. 
Before implementation, staff members underwent in-service 
training. Challenges encountered included shortages of linen, 
stock-outs of intranasal mupirocin, revisions to an existing 
checklist, and revisiting the data recording and collection 
process. Figure 3 outlines the introduced pre-operative skin 
preparation procedure in detail. 
The SWPB included pre-, intra- and post-operative measures. 
Pre-operatively, skin preparation included a full body wash and 
administration of prophylactic antibiotics 30 - 60 minutes prior 
to incision. Intra-operatively, the quality of surgical drapes was 
improved and surgical mask requirements were re-enforced; 
post-operatively, prevention focused on wound dressing using 
SOPs, caring for the echo probe used in ICU post-operatively, 
line care, urine catheter care and lastly, monitoring of serum 
blood glucose. The theatre preparation SOP (Pre-operative 
SOP, Figure 2) was replaced with a surgical site infection com-
pliance checklist. 
In 2017, SWI-prevention efforts were renewed with the aim of 
reviewing and assessing risk factors, with the placement of a 
full-time nursing sister dedicated to this task, secondary to 
joining IQIC. 
This study aimed to describe the burden, associated risk factors 
and outcomes of sternal wound sepsis in post-operative 
paediatric cardiac patients at the RCWMCH.
METHODS 
We conducted a retrospective medical record review of car-
diac surgeries over 5 years from 1 January 2012 - 31 December 
2016 at RCWMCH to identify all cases of SWI. Data were 
collected from the following sources: i) cardiac surgical data-
base; ii) cardiothoracic surgical case notes; iii) infection control 
database; and iv) National Health Laboratory Services (NHLS). 
All paediatric patients, regardless of age, who underwent car-
diac surgery at RCWMCH via the sternotomy approach during 
the study period were included and all patients who underwent 
and Medicaid Services and the US CDC developed the Sur-
gical Care Improvement Project (SCIP) in 2002.(24) This project 
was developed to standardise practice to reduce the risk of 
surgical infection and increase compliance to infection pre-
vention measures. 
Most of the SCIP initiative measures applied to the peri-
operative period. However, little substantial improvement in 
SSI rates in adults at US Veteran’s Administration Hospitals 
were seen despite adherence to the SCIP measures after a 
decade.(25) Further programmes included the development of 
a sternal wound prevention bundle (SWPB) in 2012. The 
implementation and use of a SWPB in paediatric cardiac 
patients recently demonstrated both a standardisation of peri-
operative care and a significant reduction in SWI rates in 
patients with DSC.(23) 
The Chris Barnard Division of Cardiothoracic Surgery at the 
University of Cape Town, based at Red Cross War Memorial 
Children’s Hospital (RCWMCH), operates on ±300 paediatric 
patients per year and experiences a regular occurrence of 
SWIs. The Division recently joined the International Quality 
Improvement Collaborative (IQIC) for Congenital Heart 
Surgery in Developing World Countries, which provides 
benchmarking data for healthcare professionals and guides 
quality improvement efforts. The goal of the IQIC is to decrease 
morbidity and mortality rates at participating sites and to 
demonstrate continuous improvement in quality.(26) One of the 
key variables of interest of the IQIC is SWI, however, apart 
from early informal review prior to establishing wound care 
bundles, the incidence and outcomes of SWI at RCWMCH 
had not been systematically interrogated. 
Prior to joining IQIC, our institution used several surgical 
modalities for SWI. These include a closed-suction antibiotic 
catheter irrigation system, vacuum-assisted closure, sternal 
exploration, surgical debridement, and rewiring of the ster-
num. Post-operatively, if any clinical evidence of SWI is de-
tected, empiric second-line broad-spectrum antibiotics are 
initiated as per hospital nosocomial protocol. Broad-spectrum 
coverage is targeted at methicillin-resistant gram-positive and 
gram-negative organisms. Once the organism has been con-
firmed, either on blood or tissue specimen (obtained in 
theatre or tissue swab at bedside), culture-directed therapy 
is initiated for a minimum of 4 - 6 weeks maximum – if a 
DSWI diagnosis has been confirmed. The hospital’s infectious 
disease team is consulted for appropriate antibiotics and dura-
tion of treatment. 



















Bed/cot/incubator clean and covered with clean hospital linen.
Finger and toenails are short and clean. Nail polish removed.
Hair and scalp washed with Bioscrub, thoroughly rinsed off and dried properly.
Bioscrub was lathered on skin using a disposable wash cloth.
Patient was washed in circular movements from face downward.
Patient is well washed under armpits, behind the ears, between toes and fi ngers and around the groin area.
Patient was thoroughly rinsed off in shower, with shower head or in basin with clean water.
Patient properly dried with a clean hospital towel.
Patient dressed in clean theatre gown.
Signature
FIGURE 3: Surgical site infection compliance checklist.
Pre-operatively – 




ICU nursing staff to complete
Ward: ....................................................... Time and date Time of second antibiotic dose given?  .....................
Time and date that the patient 
received the fi rst wash 








Time and date the second wash 
done according to the SOP ..................................
Was the prescrub done? YES NO
Did the dressing meet the 
criteria to be changed?
YES NO
Skin was cleaned with 
chlorhexidine?
YES NO Was the dressing changed? YES NO
Was the neck and sternum dry 
before it was draped?
YES NO
Highest glucose reading on 
ABG over last 24 hours? ...........mmol/L
Was lobane applied prior 
to incision?
YES NO





Were the lines removed within 
4 hours of decision?
YES NO
Was an echo done? YES NO
Can the urinary catheter 
be removed?
YES NO
What type of echo? ..........................................................
Was urinary catheter removed 
within 3 hours of decision?
YES NO
Was the sternum closed? YES NO Was an echo done? YES NO
If left open, what dressing was applied?
......................................................................................................
......................................................................................................
If an echo was done was the 
echo probe used according 
the SOP?
YES NO
Date and  time the drains were 
removed? ..........................
82
STERNAL WOUND SEPSIS BURDEN
expressed as means with standard deviations (mean ±SD) or 
medians with interquartile ranges [median (IQR)] depending 
on normality of the data, while categorical variables are 
expressed as frequencies and percentages. Group differences 
in categorical variables were tested using Fisher exact tests, 
since group numbers were small and the large number 
assumption for chi-square tests did not apply. Student t-tests 
or Mann Whitney tests were applied to test associations 
between continuous variables and the wound type/mortality 
outcome depending on normality. The value for statistical signi-
ficance was set at p-value = 0.05. 
RESULTS
The demographic, clinical presentation, type of surgery, wound 
features and microbiological culture variables are presented in 
Tables l – V stratified by type of wound infection, viz deep or 
superficial. Data by mortality are presented in Table Vl and 
Figure 6.
A total of 1 669 paediatric patients underwent cardiac surgery 
during the study period. Of those, 1 319 (79%) had median 
sternotomies while 350 (21%) were performed via other 
approaches (left posterolateral thoracotomy, right postero-
lateral thoracotomy, left anterior thoracotomy, right anterior 
thoracotomy) and were thus excluded. Thirty four patients 
(2.6%), or 0.04 per 1 000 population with a 95% confidence 
thoracic surgery for non-cardiac conditions and cardiac sur-
geries other than the sternotomy approach were excluded. 
Ethics approval for the study (HREC 777/2017) was obtained 
from the University of Cape Town Human Research Ethics 
Committee with a waiver of parental consent. A REDCap™ 
database hosted on a UCT-secured server was used for 
recording and managing data. 
Data Collection
Medical records were reviewed for each patient and subject 
identification numbers were assigned in lieu of actual names for 
data collection. Outcome variables were grouped as demo-
graphics, surgery, culture isolates, and morbidity and mortality. 
Demographic data included sex, age, genetic associations and 
the type of congenital heart disease. Surgery variables were 
length of bypass and cross-clamp times, number of postoperative 
ICU days, inotropic support, antibiotic prophylaxis and 
ventilation duration. Culture isolates focused on the number of 
positive isolates and the most common pathogen isolated. 
Outcomes included morbidity and mortality.
Data analysis
Stata 16(27) was used for data analysis. The incidence of DWSI 
and SSWI among all identified cardiac surgical patients is 
presented as percentages and as per 1 000 population with 
95% confidence intervals (95% CI). Continuous variables are 






























































































































































































FIGURE 6: Deaths and total cases per year





















post-surgery. Only one patient had a total erosion of sternum 
due to multiple debridement (Figure 5). Seven patients died 
from complications of SWI; 4 of these patients had DSWI and 
3 had SSWI. Those who developed DSWI were older at 
8.1 months (IQR: 0.5 - 22.7) as opposed to those with SSWI at 
1.1 months (IQR: 0.3 - 6.1). There was no significant difference 
in age, sex and genetic defects associated with the develop-
ment of either SSWI or DSWI (Table l). Twenty three of those 
with SWI (67.7%) had cyanotic congenital heart disease and the 
majority of these patients developed DSWI (72.2%). Chromo-
somal abnormalities were found in 4 (11.7%) patients in this 
cohort, of which 3 (8.8%) were trisomy 21 and 1 (2.9%) had 
confirmed chromosome 22q deletion syndrome.
Table ll describes the surgical caseload in detail. Most cases 
were elective (73.5%), the mean bypass and cross-clamp times 
were 131.4 minutes (±SD73.9) and 83.2 minutes (±SD 49.4) 
respectively. Most patients (32/94) needed post-operative 
inotropic support with adrenaline for a median duration of 1.8 
days. All patients were ventilated post-operatively according 
to cardiac intensive care protocols, with a median time of 
61.4 hours (IQR: 29 - 146). This excluded patients with missing 
data. Intensive care unit (ICU) stay was 7.1 days (IQR: 3.6 - 
16.1), and six (17.7%) patients had DSC. None of these indices 
were statistically significant in either of the DSWI or SSWI 
groups. However, trends were noted when comparing DSWI 
with SSWI variables. 
DSWI patients had prolonged duration of ICU stay and 
ventilation time when compared to SSWI with a median ICU 
stay of 8.6 days vs. 3.9 days for SSWI. DSWI patients had an 
average ventilation duration of 107.8 vs. 58 hours for SSWI. 
DSWI patients had a shorter mean duration between anti-
biotics administration to incision time of 57.1 minutes (±SD 
22.2) compared to those with SSWI of 81.7 minutes (SD ± 
35.5), p 0.03.
Table lll illustrates the distribution of DSWI and SSWI features. 
All patients who met criteria for SSWI presented differently. 
Purulent drainage and localised swelling were the most common 
presentations, at 56% and 50% respectively.
The 2 major features present in all DSWI patients were puru-
lent drainage (77.8%) and spontaneous dehiscence (61.1%). 
Osteomyelitis was noted in 3 (16.7%) DSWI patients. One 
patient had a total erosion of sternum due to multiple 
debridement.
interval (0.02 - 0.49), developed sternal wound sepsis. Eighteen 
of these patients developed DSWI, while 16 developed SSWI. 
Twenty two of the 34 patients developed SWI during hospi-
talisation post-cardiac surgery, while the rest developed wound 
infection post-discharge and were readmitted for treatment. 
A total of 1.5% of the patients who developed SWI post-
surgery showed symptoms within 1 week (before day 7), and 
the rest developed SWI in the second week (after day 14) 
FIGURE 5: Deep sternal wound infection patient 
post-debridement.
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DSWI was a maximum of 48 days with antimicrobials and a 
maximum of 21 days for SSWI.
The infection control team’s assessment of weekly compliance 
with the overall SSI bundle from January 2015 - August 2017 
is illustrated in Figure 4. Of the 34 patients included in our 
study, 15 patients’ medical records contained only the pre-
operative SOP. However, these patients were treated before 
the SWPB checklist was implemented. Another 16 patient 
records, both before and after the implementation of the 
checklist, contained neither the pre-operative SOP nor the 
new SWPB checklist. Three folders were incomplete and 
therefore no assessment of these elements could be made. 
Twenty two children (64%) had positive identifiable cultures 
and 12 children (35%) were culture-negative but met the 
criteria for SWI. The most common pathogens isolated were 
methicillin-resistant S. aureus (MRSA) followed by Coagulase-
negative S. aureus, Klebsiella pneumonia, P. aeruginosa and 
enterococcus species. Three unusual organisms (Candida 
albicans, Acinetobacter baumannii and Proteus mirabilis) were 
identified in 2 DSWI patients. No unusual organisms were 
identified in the SSWI group.  
As illustrated in Table V, the median duration of antibiotic use 
was 12.5 days (IQR [7 - 40]). Although not statistically significant 
(p=0.89), patients with DSWI required more treatments in 
theatre than those with SWI. The duration of treatment for 

















Previous surgery, n (%) 4 (15) 2 (11.1) 2 (12.5) 0.90















































Antibiotic admission to prior incision 
(mins), mean (±SD)
68.1 (31) 57.1 (22.2) 81.7 (35.5) 0.03








Bypass duration (mins), mean (±SD) 131.4 (73.9) 146.3 (76.7) 109.2 (67.2) 0.23 
Cross clamp duration (mins), mean (±SD) 83.2 (49.4) 81.5 (46.5) 85.5 (55.3) 0.84





















Three were re-admitted from home with overwhelming 
septicaemia as a complication of SWI, 4 developed SWI post-
operatively as inpatients by day-14 post-surgery. Two of the 
3 patients who were re-admitted had a previous SWI diag-
nosed before discharge. They received antibiotics and multiple 
theatre debridement treatments prior to discharge and had 
been deemed sepsis-free and fit for discharge. The third patient 
had no SWI complications noted prior to discharge. 
Five patients died from septicaemia secondary to SWI; 2 
patients died from overwhelming septicaemia secondary to 
pneumonia. One of the latter died from hypoxia secondary to 
carbapenem-resistant Klebsiella pneumonia on a background 
of severe chronic lung disease and the other had severe aden-
ovirus pneumonia. However, both these patients had been 
treated for culture-positive SWIs a month prior.
DISCUSSION
Overall, SWI in post-operative paediatric cardiac patients at 
our institution was associated with significant morbidity and 
mortality. Our cohort had an incidence of DSWI of 1.3%, which 
is similar to reported worldwide values of 1% - 5%.(11) 
We noted that younger age was not a significant risk factor, 
but there was a trend toward DSWI developing in the older 
age group of 11.5 months interquartile range (IQR, 0.6 - 19.5 
months). Although some studies showed that the presence of 
genetic abnormalities was a risk factor for SSWIs, our findings 
indicate that genetic abnormalities and DSC were not risk 
factors in our context, as only 4 of the 20 patients had 
chromosomal abnormalities and/or DSC. 
Table IV shows the pathogens found that are in keeping with 
the literature (Staphylococcal, Klebsiella and Pseudomonas 
infections). We observed a difference in the pathogens causing 
infections where more unusual pathogens (Candida albicans, 
Acinetobacter, and Proteus) were identified. However, Staphy-
lococcus aureus was still the most common pathogen causing 
infection.
Of the seven (20%) patients who died from SSI complications, 
4 had DSWI and 3 had SSWI. Tables Vl (a-c) outline the 
comparisons between these patients and the majority who 
survived. Of the 4 patients with DSWI, 3 had emergency 
surgery for complex cyanotic CHD and 4 had elective surgery. 






















































Antibiotic days, median (IQR) 12.5 (7 - 40) 9 (6 - 35) 17.5 (9 - 42) 0.08







Superfi cial wound features
Pain and tenderness, n (%) 5 (31.3)
Localised swelling, n (%) 8 (50)
Redness or heat, n (%) 7 (43.8)
Purulent drainage, n (%) 9 (56.3)
Deep wound features
Spontaneous incisional dehiscence, n (%) 11 (61.1)
Serosanguineous drainage, n (%) 3 (16.7)
Purulent drainage, n (%) 14 (77.8)
Osteomyelitis, n (%) 3 (16.7)
Mediastinitis, n (%) 3 (16.7)
Widespread cellulitis, n (%) 3 (16.7)
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Genetic associations, n (%)
22q microdeletion
1 (2.9) 1 (14.3) 0 0.05
Delayed sternal closure, n (%) 6 (17.7) 3 (42.9) 3 (11.1) 0.05
Antibiotic admission to prior incision (mins), 
mean (±SD)
68.1 (31) 56.6 (24.2) 70.5 (32.1) 0.37
Bypass duration (mins), mean (±SD) 131.4 (73.9) 106 (90.5) 137.8 (70.5) 0.40
Cross clamp duration (mins), mean (±SD) 83.2 (49.4) 46.4 (62.0) 92 (43.1) 0.06














Adrenaline, n (%) 29 (85.3) 6 (85.7) 23 (85.2) 0.97























Age at surgery in months, median (IQR) 2.9 (0.8 - 2.0) 3.5 (0.3 - 24.7) 2.4 (0.8 - 12.0) 0.80


























ICU duration (days), median (IQR) 7.1 (3.6 - 16.1) 8.6 (5.2 - 16.1) 3.9 (2.9 - 17.2) 0.29
Antibiotic days, median (IQR) 12.5 (7 - 40) 9 (6 - 35) 17.5 (9 - 42) 0.08
Number of treatments, median (IQR) 2.0 (1.0 - 4.0) 2.5 (1.0 - 3.0) 2 (1.0 - 4.0) 0.89
Length of hospital stay (days), median IIQR) 28.5 (2 - 42) 29 (22 - 49) 27.5 (16.5 - 41) 0.78













Overall, there is some evidence suggesting that surgical anti-
microbial prophylaxis administration of more than 120 minutes 
prior to incision increases the risk of SSI compared to admini-
stration within 120 minutes.(28) It is not possible to establish 
the precise optimal timing within the 120-minute interval.(28) 
No significant difference was found between different time 
intervals within the 120-minute period, for example, within 
120 - 60 minutes prior to incision vs. within the 60 - 0 minute 
period prior to incision, or within 60 - 30 minutes prior to 
incision vs. within 30 - 0 minutes prior to incision.(29) 
The current practice at RCWMCH is administration of cefa-
zolin 30 minutes prior to incision, then every 8 hours for the 
first 24 hours. Our study found a mean time of 81.7 minutes 
in the SSWI group – longer than the recommended 60-minute 
minimum. Despite the increased mean time, no association 
was found between this time period and the development of 
SSWI. We therefore suggest a more stringent application of 
the timing of the intravenous antibiotics and a review of future 
cases. Our study results show no difference in the total number 
of theatre treatments received between the 2 groups. 
As discussed, the SWPB for SSIs at RCWMCH was established 
in September 2014 – midway through the review period of 
this study – and encountered several challenges. We found 
no documentation of the SSI Compliance Checklist or pre-
operative SOP in 16 of the patients’ records retrieved for our 
study. Of note, this included 12 patients following the imple-
mentation of the SWPB. This was attributed to a lack of con-
tinuity and availability of staff. 
Most of our patients required ventilatory support post-opera-
tively. A median bypass time of 140 minutes in all patients who 
had SSWI was noted. This is in keeping with the literature 
suggesting that bypass time of longer than 1 hour, significant 
post-operative bleeding, and a low cardiac output state per-
sisting for more than 24 hours post-operatively are risk factors 
for development of SSWIs.(17,18) 
We identified unusual organisms, not typical of the organisms 
identified in the review of the literature. Although our patients 
had some typical organisms, in 3 cases we isolated Candida 
albicans, Acinetobacter and Proteus organisms, which are 
different from the previous studies. All these patients with 
unusual organisms had DSWI. 
Participating in IQIC now provides a formalised method for 
documenting wound sepsis and pre-operative status of 
patients, and facilitates more stringent record-keeping of 
treatment regimens in the hopes of gaining new insights and a 
more accurate reflection of our patients.(26) 
The current guidlines for surgical antimicrobial prophylaxis 
recommends incision time to take place WITHiN 60 minutes 
of administration of the antibiotics.(28) More evidence shows 
that prophylactic antibiotics administered after skin incision or 
more than 60 minutes before skin incision reduces the effec-
tiveness of antibiotics.(28) However, these recommendations are 
not based on randomised trials, systematic reviews and/or 
meta-analyses.(28) 







Spontaneous incisional dehiscence, n (%) 11 (32.4) 1 (14.3) 10 (37.0) 0.25
Serosanguineous drainage, n (%) 3 (8.8) 1 (14.3) 2 (7.4) 0.57
Purulent drainage, n (%) 14 (41.2) 2 (28.6) 12 (44.4) 0.45
Osteomyelitis, n (%) 3 (8.8) 0 3 (11.1) 0.36
Mediastinitis, n (%) 3 (8.8) 2 (28.6) 1 (3.7) 0.04
Widespread cellulitis, n (%) 3 (8.8) 1 (14.3) 2 (7.4) 0.57
Antibiotic days, median (IQR) 12.5 (7 - 40) 12 (8 - 30) 14 (7 - 42) 0.67
Number of treatments, median (IQR) 2.0 (1.0 - 4.0) 3.0 (1.0 - 4.0) 2 (1.0 - 4.0) 0.98
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Figure 4 shows the overall weekly assessment of compliance 
to the SWPB. From January 2016,116 compliance checklists 
were completed for the year. However, none of this docu-
mentation was found in the medical records of the patients 
identified for this review. In the initial stages, the SWPB was 
rolled out as a trial and there was no strict, formal handover 
procedure for the completed checklist forms, thus accounting 
for the missing documentation. 
Study Limitations
Inherent to a retrospective study, limitations include missing 
data in the medical records, inaccurate information, and the lack 
of information regarding mortality and morbidity for these 
patients after discharge. Most information about the process 
and challenges encountered during the implementation of the 
SWPB was not readily available. There was no long-term 
follow-up, as the study is limited to 5 years. Of interest would 
have been an assessment of our patients post-discharge, recur-
rence of SWI, and the physical and psychological effects of SWI.
Implications for future research and 
clinical practice
In conducting this study, we have created a database that can 
be used for a prospective registry of sternal wound infections 
in our patient population. This would allow for better docu-
mentation of risk factors, outcomes and preventative measures 
and would allow us to add variables such as ECMO and ASA. 
The results of this study have reinforced improved quality 
practices: the use of echo sleeves has been implemented in the 
theatre, patients with any symptoms of SWI are now being 
flagged early, and the use of SWPB checklists is instituted 
immediately post-operatively in ICU. 
As this is the first study to review the risk factors and burden 
of SWI before and since the implementation of the SWPB, it 
provides the opportunity to evaluate the outcomes of the 
bundle. The incidence of SWI in our institution is comparable 
to the global literature, but carries significant morbidity. In 
addition, DSWI carries a mortality rate of 20%. Our institution 
strongly supports the quality improvement procedures such 
as the SWPB implemented in late 2014. However, the rate of 
SWI implies ongoing monitoring and evaluation of the SWPB 
is necessary and more stringent adherence to the protocol may 
result in better outcomes. 
ACKNOWLEDGEMENTS
Many thanks to the RCWMCH medical records staff who 
assisted with locating and providing patients’ medical files for 














1. Okonta KE, Anbarasu M. Sternal wound infection following open heart 
surgery: Appraisal of incidence, risk factors, changing bacteriologic pattern 
and treatment outcome. Indian J Thorac Cardiovasc Surg. 2011;27:28-32.
2. Woodward CS, Son M, Taylor R, et al. Prevention of sternal wound infection 
in paediatric cardiac surgery: A protocolised approach. World Journal for 
Paediatric & Congenital Heart Surgery. 2012;3(4):463-469.
3. Fowler VG, Jr., O'Brien SM, Muhlbaier LH, et al. Clinical predictors of major 
infections after cardiac surgery. Circulation. 2005;112(9 Suppl):I358-I365.
4. Mrowczynski W, Wojtalik M, Zawadzka D, et al. Infection risk factors in 
paediatric cardiac surgery. Asian Cardiovascular & Thoracic Annals. 2002;
10(4):329-333.
5. Levy I, Ovadia B, Erez E, et al. Nosocomial infections after cardiac surgery 
in infants and children: Incidence and risk factors. The Journal of Hospital 
Infection. 2003;53(2):111-116.
6. Sarvikivi E, Lyytikainen O, Nieminen H, et al. Nosocomial infections after 
paediatric cardiac surgery. American Journal of Infection Control. 2008;
36(8):564-569.
7. Barker GM, O'Brien SM, Welke KF, et al. Major infection after paediatric 
cardiac surgery: A risk estimation model. The Annals of Thoracic Surgery. 
2010;89(3):843-850.
8. Ridderstolpe L, Gill H, Granfeldt H, et al. Superficial and deep sternal wound 
complications: Incidence, risk factors and mortality. European Journal of 
Cardio-Thoracic Surgery: Official Journal of the European Association for 
Cardio-thoracic Surgery. 2001;20(6):1168-1175.
9. Salehi Omran A, Karimi A, Ahmadi SH, et al. Superficial and deep sternal 
wound infection after more than 9 000 coronary artery bypass graft (CABG): 
Incidence, risk factors and mortality. BMC Infectious Diseases. 2007;7:112.
10. Singh K, Anderson E, Harper JG. Overview and management of sternal 
wound infection. Seminars in Plastic Surgery. 2011;25(1):25-33.
11. Gummert JF, Barten MJ, Hans C, et al. Mediastinitis and cardiac surgery – an 
updated risk factor analysis in 10 373 consecutive adult patients. The 
Thoracic and Cardiovascular Surgeon. 2002;50(2):87-91.
12. Ang LB, Veloria EN, Evanina EY, et al. Mediastinitis and blood transfusion in 
cardiac surgery: A systematic review. Heart & Lung: the Journal of Critical 
Care. 2012;41(3):255-263.
13. Finkelstein R, Rabino G, Mashiah T, et al. Surgical site infection rates following 
cardiac surgery: The impact of a 6-year infection control programme. 
American Journal of Infection Control. 2005;33(8):450-454.
14. Lemaignen A, Birgand G, Ghodhbane W, et al. Sternal wound infection 
after cardiac surgery: Incidence and risk factors according to clinical pre-
sentation. Clinical Microbiology and Infection: The official publication of the 
European Society of Clinical Microbiology and Infectious Diseases. 2015;
21(7):674 e11-8.
15. Lepelletier D, Perron S, Bizouarn P, et al. Surgical-site infection after cardiac 
surgery: Incidence, microbiology, and risk factors. Infection Control and 
Hospital Epidemiology. 2005;26(5):466-472.
16. Medalion B, Mohr R, Frid O, et al. Should bilateral internal thoracic artery 
grafting be used in elderly patients undergoing coronary artery bypass 
grafting? Circulation. 2013;127(22):2186-2193.
17. Rosanova MT, Allaria A, Santillan A, et al. Risk factors for infection after 
cardiovascular surgery in children in Argentina. The Brazilian Journal of 
Infectious Diseases: an official publication of the Brazilian Society of Infectious 
Diseases. 2009;13(6):414-416.
18. Lepelletier D, Bourigault C, Roussel JC, et al. Epidemiology and prevention 
of surgical site infections after cardiac surgery. Medecine et Maladies 
Infectieuses. 2013;43(10):403-409.
19. Pollock EM, Ford-Jones EL, Rebeyka I, et al. Early nosocomial infections in 
paediatric cardiovascular surgery patients. Critical Care Medicine. 1990;
18(4):378-384.
20. Mehta PA, Cunningham CK, Colella CB, et al. Risk factors for sternal wound 
and other infections in paediatric cardiac surgery patients. The Paediatric 
Infectious Disease Journal. 2000;19(10):1000-1004.
21. Allpress AL, Rosenthal GL, Goodrich KM, et al. Risk factors for surgical site 
infections after paediatric cardiovascular surgery. The Paediatric Infectious 
Disease Journal. 2004;23(3):231-234.
22. Group PMS. Risk factors for deep sternal wound infection after ster-
notomy: A prospective, multicenter study. J Thorac Cardiovasc Surg. 1996;
111(6):1200-1207.
23. Delgado-Corcoran C, Van Dorn CS, Pribble C, et al. Reducing paediatric 
sternal wound infections: A quality improvement project. Paediatric Critical 
Care Medicine: A Journal of the Society of Critical Care Medicine and the 
World Federation of Paediatric Intensive and Critical Care Societies. 
2017;18(5):461-468.
24. Rosenberger LH, Politano AD, Sawyer RG. The surgical care improvement 
project and prevention of post-operative infection, including surgical site 
infection. Surgical infections. 2011;12(3):163-168.
25. Hawn MT, Vick CC, Richman J, et al. Surgical site infection prevention: Time 
to move beyond the surgical care improvement programme. Annals of 
Surgery. 2011;254(3):494-499; discussion 9-501.
26. Balachandran R, Kappanayil M, Sen AC, et al. Impact of the International 
Quality Improvement Collaborative on outcomes after congenital heart 
surgery: A single center experience in a developing economy. Annals of 
Cardiac Anaesthesia. 2015;18(1):52-57.
27. StataCorp. Statistical Software: Release 16. College Station,TX: StatacorpLLC; 
2019.   
28.  WHO Global Guidelines for the Prevention of Surgical Site Infection Web 
Appendix 5 Summary of a systematic review on optimal timing for 
preoperative surgical antibiotic prophylaxis. https://www.who.int/gpsc/ssi-
prevention-guidelines/en/ November 2018 (accessed 28 March 2020).
